CN Bio’s Lung-on-a-Chip technology will enable research into therapies to prevent interstitial lung disease and long-term lung impairment, following SARS-CoV-2 infection CN Bio, a leading cell culture company, that has ...
Bioprinting holds enormous promise in medicine in areas such as tissue engineering, regenerative medicine and drug discovery. AXT has identified the potential for this technology to print tissues and even ...
DELMIC METEOR cryo-CLEM, a new fluorescence microscope (FM) that can be integrated into a cryo FIB/SEM simplifying cryo-ET workflows.
AXT is excited to add the Vieworks range of bio-imaging systems to their preclinical imaging product portfolio. Their in-vivo imaging systems provide outstanding performance in bioluminescent and fluorescent imaging and represents excellent value. The VISQUE ...
Medical research is an important part of the Australian research landscape and one that AXT is committed to supporting. Specifically, preclinical imaging is key to the development of new technologies ...
With Australia having a vast wealth of mineral resources and mining being a key factor in the nations’ economy, understanding mineral deposits is of key importance. Queensland University of Technology ...
AXT has further consolidated its position as a diversified supplier of life science products with the addition of LabTIE International’s innovative range of laboratory products and consumables. Their range of ...
AXT and Delmic are proud of a first in the world installation. They recently installed a Delmic SPARC cathodoluminescence (CL) and SECOM correlative light and scanning electron microscope (CLEM) on ...
AXT are proud to announce that they have partnered with France-based Poietis to bring their next-generation bioprinting platforms to Australia. The NGB (Next Generation Bioprinting) system is a world first using laser-assisted bioprinting technology to print cells (from aggregates ...
AXT are proud to announce that they have just expanded their life science product portfolio with the addition of Fluicell’s innovative tissue engineering systems. The new agreement will see AXT ...
